Incidence of anaerobic bacteria in patients with suspected pneumonia in surgical Intensive Care Unit

T Clavier1, P Gouin, N Frebourg

  • 1Department of Anesthesiology and Intensive Care, Rouen University Hospital, Rouen, France - thomas.clavier@chu-rouen.fr.

Minerva Anestesiologica
|January 30, 2014
PubMed
Abstract

Insights

Pulmonary anaerobes were detected in 8.2% of surgical intensive care unit (ICU) patients with suspected pneumonia. Enteral nutrition was identified as a significant risk factor for anaerobic lung infections in this patient group.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pulmonary Medicine

Background:

  • Limited data exists on the incidence of pulmonary anaerobes in surgical Intensive Care Units (ICUs).
  • Investigating anaerobic bacterial presence is crucial for understanding pneumonia in critically ill surgical patients.

Purpose of the Study:

  • To determine the incidence of anaerobic bacteria in the lungs of patients in a surgical ICU with suspected pneumonia.
  • To identify potential risk factors associated with anaerobic lung infections in this population.

Main Methods:

  • Prospective observational, single-center study over 30 months in a surgical ICU.
  • Protected distal bronchial sampling (PDBS) with minilavage under bronchoscopy for aerobic and anaerobic cultures.
  • Univariate and multivariate statistical analyses to identify risk factors for anaerobes.

Main Results:

  • Anaerobic bacteria were found in 8.2% of samples from 117 patients; 81.8% of these also had aerobic bacteria.
  • Enteral feeding was a significant risk factor for anaerobes in both univariate (P=0.02) and multivariate (OR=11.8, P=0.025) analyses.
  • No significant differences were observed in aspiration, survival, length of stay, or mechanical ventilation duration between groups.

Conclusions:

  • Anaerobic bacteria are present in surgical ICU patients with suspected pneumonia at an incidence comparable to medical ICUs.
  • Enteral nutrition is a key risk factor for anaerobic lung infections in surgical ICU patients.
  • Findings align with recent literature on anaerobic morbidity in critically ill patients.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.2K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.2K